{"nct_id":"NCT01427933","title":"A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer","status":"COMPLETED","status_verified_date":"2016-12","start_date":"2011-11","start_date_type":null,"primary_completion_date":"2013-09","primary_completion_date_type":"ACTUAL","completion_date":"2014-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}